Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 70,000 shares at $18.65 ($1.3M) on 2017-02-01, disclosed to the SEC on 2017-02-03.
Seasonal sale ($1.3M) by EVP, Scientific Strategy & CSO — this insider has traded EXEL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |